Alligator Bioscience publishes prospectus in connection with forthcoming rights issue
The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has, in connection with the rights issue of shares which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the Annual General Meeting on May 5, 2020 (the "Rights Issue"), prepared a prospectus (the “Prospectus”) that today has been approved and registered by the Swedish Financial Supervisory Authority. To ensure continued successful development in accordance with the Company's business plan and strategy, the Board of Directors of Alligator has resolved